NCT05268042

Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents

CompletedNAINTERVENTIONAL

Trial Details

Start: 2022-05-01Est. Completion: 2026-07-21

Enrollment target: 50 participants

Locations

Non-alcoholic Fatty Liver Disease

The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis…

Chandler, United StatesEst. completion Mar 29, 2028

Non-alcoholic Fatty Liver Disease

This study will evaluate the safety and tolerability of Efimosfermin Alfa for participants with known or suspected MASH …

Arcadia, United StatesEst. completion Mar 24, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.